Dr. Joshua Purow, MD
What this data tells you about Dr. Purow
Dr. Joshua Purow is a cardiovascular disease in Fort Lauderdale, FL, with 20 years in practice. Based on federal Medicare data, Dr. Purow performed 5,297 Medicare services across 4,041 unique beneficiaries.
Between the years covered by Open Payments, Dr. Purow received a total of $20,398 from 27 pharmaceutical and/or device companies across 228 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Purow is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| EKG interpretation and report | 1,491 | $6 | $31 |
| Office visit, established patient (30-39 min) | 1,105 | $72 | $328 |
| Echocardiogram, transthoracic | 503 | $51 | $450 |
| Hospital follow-up visit, moderate complexity | 304 | $64 | $254 |
| Hospital follow-up visit, high complexity | 184 | $94 | $382 |
| Office visit, established patient (20-29 min) | 169 | $47 | $223 |
| Initial hospital admission, moderate complexity | 155 | $107 | $461 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 147 | $11 | $44 |
| New patient office visit (45-59 min) | 137 | $99 | $453 |
| Office visit, established patient, complex (40-54 min) | 117 | $112 | $482 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 105 | $16 | $73 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 105 | $11 | $48 |
| Cardiac catheterization | 95 | $196 | $1,068 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 88 | $59 | $1,534 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 77 | $15 | $191 |
| Initial hospital admission, high complexity | 72 | $142 | $675 |
| 3d radiographic procedure | 70 | $8 | $32 |
| Remote pacemaker monitoring, 90 days | 59 | $21 | $105 |
| Coronary stent placement | 56 | $434 | $2,171 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 41 | $271 | $1,350 |
| Programming of dual lead pacemaker system | 35 | $26 | $266 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 25 | $27 | $179 |
| Replacement of aortic valve through the skin and femoral artery | 19 | $639 | $4,431 |
| Ultrasound of heart, follow-up | 18 | $20 | $90 |
| Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | 17 | $61 | $267 |
| New patient office visit, complex (60-74 min) | 17 | $149 | $614 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 16 | $24 | $188 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 15 | $6 | $24 |
| Ultrasound of both sides of head and neck blood flow | 15 | $24 | $644 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 14 | $19 | $87 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $2 | $40 |
| New patient office visit (30-44 min) | 12 | $63 | $283 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (69%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in cardiovascular disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Purow is a clinical cardiology specialist, with above-average Medicare volume (top 19% in FL), and high industry engagement (speaking/promotional, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Purow experienced with ekg interpretation and report?
Does Dr. Purow receive payments from pharmaceutical companies?
How do Dr. Purow's costs compare to other cardiovascular diseases in Fort Lauderdale?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology